A team of scientists from the National Institutes of Health (NIH) recently found the genetic mutation that causes a rare kind of pediatric progressive neuropathy -- and they may have developed a therapeutic target to treat the disease.
The ALS Association and Cytokinetics Inc. recently announced that they have chosen to continue and broaden their current partnership against ALS, furthering their support of various initiatives and programs.
Leaders at AbbVie, a worldwide biopharmaceutical company, recently announced that it has launched its phase-three clinical trial concerning venetoclax, which is designed to treat patients who have relapsed or refractory multiple myeloma.
The Human Connectome Project (HCP), part of the National Institutes of Health (NIH), recently announced that its new software has mapped 180 specific regions within the brain’s cortex automatically, more than doubling the previous number.
According to the latest American Heart Association 'Rapid Access Journal Report,' evidence suggests that patients who experienced a heart attack may improve their heart function and decrease scarring by taking high omega-3 fatty acids doses via fish oil capsules for six months.
The ALS Ice Bucket Challenge first gained popularity in 2014, effectively fundraising more than $100 million to support research for treatments and cures for amyotrophic lateral sclerosis (ALS), which is also called Lou Gehrig’s disease.
The top leaders of Parent Project Muscular Dystrophy (PPMD), Hope for Gabe and the Foundation to Eradicate Duchenne recently expressed their support for the 21st Century Cures Act, promoting the related #CuresNow campaign.
Eli Lilly and Company recently announced that its latest phase-two study with tau imaging agent flortaucipir (AV -1451) shows a potential connection between tau pathology tangles and the progression of Alzheimer’s.
Thanks to donations from the ALS Association’s ALS Ice Bucket Challenge, scientists have made significant progress in Project MinE’s worldwide gene sequencing work, identifying NEK1 as the new ALS gene.
Last week, President Barack Obama and his administration began taking proactive action to develop a legislation that will fight the U.S. opioid epidemic, a fight which the bipartisan House Energy and Commerce Committee has already started.
Leaders with the federal Interagency Autism Coordinating Committee (IACC) recently held their quarterly meeting to exchange new information and discuss how to improve support for adults and college students, among other issues.
The National Institutes of Health (NIH) recently formed a team of program managers and scientists to find the best practical application approaches for reducing HIV transmissions from mothers to their children.
Leaders with the American Diabetes Association (ADA) recently praised the progress that has been made in Medicare coverage for diabetics, signaling advancements for the National Diabetes Prevention Program (National DPP).
The Department of Health and Human Services’ (HHS) Office of Minority Health (OMH) recently informed the Lupus Foundation of America that there is a new grant to improve the rate of minority participants involved in lupus clinical trials.